Long-term HIV-1 virologic control in patients on a dual NRTI regimen

HIV Clinical Trials

Volumn 14, Issue 3, 2013, Pages 120-126

  Prazuck, Thierry ^a   Zucman, David ^b   Avettand Fènoël, Véronique ^c,d   Ducasse, Elodie ^a   Bornarel, Dominique ^b   Mille, Catherine ^a   Rouzioux, Christine ^c,d   Hocqueloux, Laurent ^a  

^a Centre Hospitalier Regional   (France)

^b FOCH HOSPITAL   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

CD4 nadir; Dual NRTI therapy; HIV DNA; HIV RNA; Maintenance

Indexed keywords

ABACAVIR; EMTRICITABINE; LAMIVUDINE; TENOFOVIR;

ADULT; ARTICLE; CD4 CD8 RATIO; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DRUG DOSE REGIMEN; ELECTRONIC MEDICAL RECORD; FEMALE; FOLLOW UP; GENOTYPE; HEPATITIS B; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; OUTCOME ASSESSMENT; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VIROLOGY; VIRUS LOAD;

ADULT; ANTI-HIV AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RNA, VIRAL;

EID: 84880200171     PISSN: 15284336     EISSN: 19455771     Source Type: Journal    
DOI: 10.1310/hct1403-120     Document Type: Article

References (11)

1. Yeni P. Prise en Charge Médicale des Personnes Infectées par le VIH. Paris: La Documentation Franç aise; 2010
2. Thompson MA, Aberg JA, Hoy JF, et al. Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International AIDS Society-USA panel. JAMA. 2012;308:387-402
3. Avettand-Fènoël V, Chaix M-L, Blanche S, et al. LTR realtime PCR for HIV-1 DNA quantitation in blood cells for early diagnosis in infants born to seropositive mothers treated in HAART area (ANRS CO 01). J Med Virol. 2009;81:217-223
4. Pialoux G, Raffi F, Brun-Vezinet F, et al. A randomized trial of three maintenance regimens given after three months of induction therapy with zidovudine, lamivudine, and indinavir in previously untreated HIV-1-infected patients. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team. N Engl J Med. 1998;339:1269-1276 (Pubitemid 28496192)
5. Havlir DV, Marschner IC, Hirsch MS, et al. Maintenance antiretroviral therapies in HIV infected patients with undetectable plasma HIV RNA after triple-drug therapy. AIDS Clinical Trials Group Study 343 Team. N Engl J Med. 1998;339:1261-1268 (Pubitemid 28496191)
6. Rouzioux C, Hubert J-B, Burgard M, et al. Early levels of HIV-1 DNA in peripheral blood mononuclear cells are predictive of disease progression independently of HIV-1 RNA levels and CD4+ T cell counts. J Infect Dis. 2005;192:46-55 (Pubitemid 40863856)
7. Lewin SR, Rouzioux C. HIV cure and eradication: How will we get from the laboratory to effective clinical trials ? AIDS. 2011;25:885-897
8. Lambert-Niclot S, Flandre P, Valantin M-A, et al. Factors associated with virological failure in HIV-1-infected patients receiving darunavir/ritonavir monotherapy. J Infect Dis. 2011;204:1211-1216
9. Geretti AM, Arribas JR, Lathouwers E, et al. Dynamics of cellular HIV-1 DNA levels over 144 weeks of darunavir/ ritonavir monotherapy versus triple therapy in the MONET trial. HIV Clin Trials. 2013;14:45-50
10. Hocqueloux L, Avettand-Fènoël V, Jacquot S, et al. Longterm antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts. [published online ahead of print January 25, 2013]. J Antimicrob Chemother
11. Ickovics JR, Cameron A, Zackin R, et al. Consequences and determinants of adherence to antiretroviral medication: Results from Adult AIDS Clinical Trials Group protocol 370. Antivir Ther. 2002;7:185-193 (Pubitemid 36427144)